ARCHIVES

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Broder to Discuss Centers Plan Between Meeting; Symposium Depicted To William Scott

May 11, 1990

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

Phase II Study of Veliparib Improves PFS by 35 Percent

October 31, 2014

NCI Advisory Group, Other Cancer Meetings

August 19, 1983

Panel Debates Whether DCIS Needs A New Name

September 25, 2009

Cancer Deaths Level Off For First Time, Klausner Tells House Appropriators.

February 18, 2000